TABLE 3.
Treatment characteristics
| Enoxaparin | Dalteparin or tinzaparin | |
|---|---|---|
| Patients, N | 3526 | 925 |
| Switching LMWH doses | ||
| Yes, n (%) | 1215 (34) | 197 (21) |
| Number of days until switch | ||
| Mean days ±SD | 17 ± 27 | 28 ± 28 |
| Median days (min‐max) | 8 (1‐178) | 27 (1‐150) |
| Changes of daily doses, n (%) | ||
| Increase in doses | 225 (6.4) | 46 (5.0) |
| Decrease in doses | 1095 (31) | 172 (19) |
| Both increase and decrease | 105 (3.0) | 21 (2.3) |
| Number of doses switch | ||
| 1 | 1027 (29) | 173 (19) |
| 2 | 134 (3.8) | 18 (1.9) |
| ≥3 | 54 (1.5) | 6 (0.65) |
| Regimen, n (%) | ||
| Once daily | 891 (25) | 925 (100) |
| Twice daily | 1856 (53) | 0 |
| Regimen modification | ||
| Twice daily to once daily | 687 (20) | 0 |
| Once daily to twice daily | 42 (1.2) | 0 |
| Multiple dosing changes | 50 (1.4) | 0 |
| Different drugs | 0 | 49 (5.3) |
Abbreviations: LMWH, low‐molecular‐weight heparin; SD, standard deviation.